C07K

Follow

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Subclasses

Not Available
Subclass Title
1/00 General processes for the preparation of peptides
1/02 General processes for the preparation of peptides in solution
1/04 General processes for the preparation of peptides on carriers
1/06 General processes for the preparation of peptides using protecting groups or activating agents
1/08 General processes for the preparation of peptides using protecting groups or activating agents using activating agents

more results

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
8,961,951 Baculoviruses with enhanced virion production and a method for the production of baculoviruses Jul 03, 08 Feb 24, 15 BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC., BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH
8,961,960 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases Apr 27, 11 Feb 24, 15 PANGU BIOPHARMA LIMITED, ATYR PHARMA INC.; PANGU BIOPHARMA LIMITED;
8,961,964 High concentration antibody and protein formulations Jun 21, 11 Feb 24, 15 GENENTECH, INC., GENENTECH, INC.
8,961,966 Antibodies against ERBB3 and uses thereof Oct 14, 10 Feb 24, 15 MERRIMACK PHARMACEUTICALS, INC., MERRIMACK PHARMACEUTICALS, INC.
8,961,967 Antibody Fc mutants with ablated effector functions Nov 29, 10 Feb 24, 15 JANSSEN BIOTECH, INC., JANSSEN BIOTECH, INC.
8,961,968 Human monoclonal antibodies against CD25 May 07, 12 Feb 24, 15 GENMAB A/S, GENMAB A/S
8,961,969 Antagonist antibodies against EphB3 Dec 21, 12 Feb 24, 15 XOMA TECHNOLOGY LTD., NOVARTIS AG; XOMA TECHNOLOGY LTD.;
8,961,970 Combination therapy Mar 13, 13 Feb 24, 15 NOVARTIS INSTITUTES OF BIOMEDICAL RESEARCH, INC., NOVARTIS AG; AMGEN INC.;
8,961,971 Bispecific T-cell activator antibody Dec 19, 12 Feb 24, 15 DEVELOPMENT CENTER FOR BIOTECHNOLOGY, DEVELOPMENT CENTER FOR BIOTECHNOLOGY; DCB-USA LLC;
8,961,972 Anti-N3pGlu amyloid beta peptide antibodies and uses thereof Sep 27, 13 Feb 24, 15 ELI LILLY AND COMPANY, ELI LILLY AND COMPANY
8,961,973 Multiple-variable dose regimen for treating TNFα-related disorders Mar 28, 14 Feb 24, 15 ABBVIE BIOTECHNOLOGY LTD., ABBVIE BIOTECHNOLOGY LTD.
8,961,974 Multiple-variable dose regimen for treating TNFα-related disorders Mar 28, 14 Feb 24, 15 ABBVIE BIOTECHNOLOGY LTD., ABBVIE BIOTECHNOLOGY LTD.
8,961,976 Anti-CD154 antibodies Dec 19, 13 Feb 24, 15 BIOGEN IDEC MA INC., BIOGEN IDEC MA INC.
8,961,977 Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies Feb 14, 11 Feb 24, 15 UNIVERSITY OF ROCHESTER, UNIVERSITY OF ROCHESTER
8,961,978 Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses Jul 12, 12 Feb 24, 15 CRUCELL HOLLAND B.V., CRUCELL HOLLAND B.V.
8,961,980 Monoclonal antibodies for treatment of cancer Dec 11, 12 Feb 24, 15 JOHANNES GUTENBERG-UNIVERSITAT MAINZ, GANYMED PHARMACEUTICALS AG; JOHANNES GUTENBERG-UNIVERSITAT MAINZ;
8,961,981 Targeting the neuromuscular junction for treatment Jun 19, 12 Feb 24, 15 SAINT LOUIS UNIVERSITY, SAINT LOUIS UNIVERSITY
8,961,984 Surface-coated structures and methods Oct 07, 10 Feb 24, 15 ARCH BIOPHYSICS, INC., ARCH BIOPHYSICS, INC.
8,961,985 Immunotherapy against several tumors including neuronal and brain tumors Jan 09, 12 Feb 24, 15 IMMATICS BIOTECHNOLOGIES GMBH, IMMATICS BIOTECHNOLOGIES GMBH
8,961,986 Peptide composition Dec 06, 12 Feb 24, 15 APITOPE TECHNOLOGY (BRISTOL) LIMITED, APITOPE TECHNOLOGY (BRISTOL) LIMITED

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2015/0056,132 IMMUNO-PET IMAGING OF ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR May 27, 14 Feb 26, 15 GENENTECH, INC.,
2015/0056,133 CX3CR1-TARGETING IMAGING AGENTS AND THEIR USE IN THE DIAGNOSIS AND TREATMENT OF DISEASE Aug 20, 14 Feb 26, 15 BOEHRINGER INGELHEIM INTERNATIONAL GMBH,
2015/0056,134 Nucleic Acids Encoding Human Antibodies To Sialyl-Lewis A Aug 26, 14 Feb 26, 15 MABVAX THERAPEUTICS, INC.,
2015/0056,159 The IgM and IgE Heavy Chain Domain 2 as Covalently Linked Homodimerization Modules for the Generation of Fusion Proteins with Dual Specificity Apr 16, 13 Feb 26, 15 UNIVERSIT-T STUTTGART,
2015/0056,162 Therapeutic IL-13 Polypeptides Jan 25, 13 Feb 26, 15 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY,
2015/0056,163 LEUKOTOXIN E/D AS A NEW ANTI-INFLAMMATORY AGENT AND MICROBICIDE Aug 25, 14 Feb 26, 15 ,
2015/0056,165 NOVEL CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION Aug 26, 14 Feb 26, 15 ENANTA PHARMACEUTICALS, INC.,
2015/0056,180 COMPOSITIONS COMPRISING SECRETORY - LIKE IMUNOGLOBULINS Mar 08, 13 Feb 26, 15 CSL BEHRING AG,
2015/0056,181 NANOCARRIERS WITH MULTI-PHOTON RESPONSE ELEMENTS Aug 08, 14 Feb 26, 15 THE REGENTS OF THE UNIVERSITY OF CALIFORNIA,
2015/0056,182 DRUG CONTAINING CARRIER INTO CELL FOR FORMING IMMUNE COMPLEX Nov 30, 12 Feb 26, 15 CHUGAI SEIYAKU KABUSHIKI KAISHA,
2015/0056,183 THERAPEUTIC CANINE IMMUNOGLOBULINS AND METHODS OF USING SAME May 08, 12 Feb 26, 15 NVIP PTY LTD,
2015/0056,184 Protein Belonging to the TNF Superfamily Involved in Signal Transduction, Nucleic Acids Encoding Same and Methods of Use Thereof Dec 19, 13 Feb 26, 15 THE ROCKEFELLER UNIVERSITY,
2015/0056,185 IMMUNOGLOBULIN CONSTANT REGION FC RECEPTOR BINDING AGENTS Mar 20, 14 Feb 26, 15 GLIKNIK INC.,
2015/0056,187 Humanized Antibodies That Recognize Alpha-Synuclein Jul 24, 14 Feb 26, 15 NEOTOPE BIOSCIENCES LIMITED,
2015/0056,188 JCV NEUTRALIZING ANTIBODIES Mar 15, 13 Feb 26, 15 BIOGEN IDEC MA INC.,
2015/0056,189 CDR-MODIFIED ANTI-SIGLEC-15 ANTIBODY Mar 29, 13 Feb 26, 15 DAIICHI SANKYO COMPANY, LIMITED,
2015/0056,190 DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER Mar 14, 13 Feb 26, 15 GENENTECH, INC.,
2015/0056,191 IGF1 BIOMARKER FOR IGF1R INHIBITOR THERAPY Mar 25, 13 Feb 26, 15 ,
2015/0056,195 COMPOSITIONS AND METHODS FOR INIHIBITING TUMORIGENICITY OF SENESCENT CANCER CELLS INDUCED BY CHEMOTHERAPY Aug 22, 14 Feb 26, 15 UNIVERSITE DE NICE SOPHIA ANTIPOLIS,
2015/0056,196 ANTIBODY PURIFICATION BY CATION EXCHANGE CHROMATOGRAPHY Nov 03, 14 Feb 26, 15 GENENTECH, INC.,

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

UPGRADE MEMBERSHIP CANCEL